How Toll-like Receptor 9 Plays a Key Role in the Development of Gastric Cancer and Is Linked to Epstein–Barr Virus Infection
Author:
Majewski Marek1, Mertowska Paulina2ORCID, Mertowski Sebastian2ORCID, Torres Kamil1, Grywalska Ewelina2ORCID
Affiliation:
1. Department of Plastic and Reconstructive Surgery and Microsurgery, Medical University of Lublin, 20-059 Lublin, Poland 2. Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland
Abstract
The relationship between Toll-like receptor 9 (TLR-9) signaling and its involvement with Epstein–Barr virus (EBV) in gastric cancer (GC) is complex and currently under study. This research intended to understand TLR-9’s role in certain T and B lymphocytes and the serum levels of TLR-9 in GC patients versus healthy subjects. The team explored links between these immune markers and various GC traits, such as histological grade, tumor progression stages, cancer types, and survival rates. Additionally, the research sought to find if EBV genetic material influences these immune reactions. Using flow cytometry, TLR-9 levels in different immune cells were analyzed. At the same time, the amount of TLR-9 in the serum was determined. The results showed GC patients had varied TLR-9 levels compared to healthy subjects, with specific cells showing noticeable changes. When grouped by GC attributes, key relationships emerged between TLR-9 amounts, the histological grade, progression stages, and cancer types. A notable finding was the connection between TLR-9 levels and EBV genetic presence, suggesting possible interactions between TLR-9 responses and EBV-related GC processes. Survival data also hinted at TLR-9’s potential as a predictor linked to clinical traits. Overall, this research emphasizes TLR-9’s complex role in GC’s immune responses, pinpointing its interactions with particular cells, clinical features, and EBV. The study unveils a complex web affecting GC and paves the way for new treatment avenues targeting TLR-9 pathways.
Funder
Medical University of Lublin
Subject
Cancer Research,Oncology
Reference37 articles.
1. Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., and Sitarz, R. (2020). Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. Int. J. Mol. Sci., 21. 2. Keshavjee, S.H., Moy, R.H., Reiner, S.L., Ryeom, S.W., and Yoon, S.S. (2022). Gastric Cancer and the Immune System: The Key to Improving Outcomes?. Cancers, 14. 3. Epidemiology of Gastric Cancer: Global Trends, Risk Factors and Prevention;Rawla;Gastroenterol. Rev.,2018 4. (2023, October 04). Cancer of the Stomach—Cancer Stat Facts, Available online: https://seer.cancer.gov/statfacts/html/stomach.html. 5. DidkWowska, J., Wojciechowska, U., Olasek, P., dos Santos, F.C., and Michałek, I. (2021). Nowotwory Złościwe w Polsce w 2019 Roku, Krajowy Rejestr Nowotworów. Available online: https://onkologia.org.pl/sites/default/files/publications/2022-05/Nowotwory_2019.pdf.
|
|